Ensign Peak Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Ensign Peak Advisors's EWTX Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Edgewise Therapeutics (EWTX) stake by 8.5% in Q3 2026, selling an estimated $146K and leaving 36,949 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #755.
Ensign Peak Advisors first reported a position in EWTX in Q1 2022 and has held it in 4 quarters since. The position peaked at $6.43M in Q1 2022. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Ensign Peak Advisors held 36,949 shares of Edgewise Therapeutics worth $1.5M as of Q3 2026.
- Ensign Peak Advisors sold 3,430 Edgewise Therapeutics shares in Q3 2026, an estimated $146K.
- Edgewise Therapeutics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #755 holding.
- Ensign Peak Advisors first reported a position in Edgewise Therapeutics in Q1 2022 and has held it in 4 quarters since.
- Ensign Peak Advisors's Edgewise Therapeutics position peaked at $6.43M in Q1 2022.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.